Literature DB >> 31699838

Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: preliminary evidence from the AmbOx Trial.

Jennifer A Whitty1,2, Jenny Rankin3, Dina Visca4,5,6, Vicky Tsipouri5,6, Letizia Mori5,6, Lisa Spencer7, Huzaifa Adamali8, Toby M Maher6, Nicholas S Hopkinson6, Surinder S Birring9, Morag Farquhar10, Athol U Wells5,6, Piersante Sestini11, Elisabetta A Renzoni5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31699838     DOI： 10.1183/13993003.01157-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

Review 1.  Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases.

Authors:  Magda Viani; Vittoria Ventura; Francesco Bianchi; Miriana d'Alessandro; Laura Bergantini; Piersante Sestini; Elena Bargagli
Journal:  Biomolecules       Date:  2022-05-18

2.  A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies.

Authors:  Alyson W Wong; John Koo; Christopher J Ryerson; Mohsen Sadatsafavi; Wenjia Chen
Journal:  BMC Pulm Med       Date:  2022-04-20       Impact factor: 3.320
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.